N-(5-((2-METHYLPHENYL)METHYL)-2-THIAZOLYL)-4-OXO-1,2,3-BENZOTRIAZINE-3(4H)-PROPANAMIDE
UNII R8F88SC626
Substance Identification & Data
This profile provides standardized clinical and technical data for N-(5-((2-methylphenyl)methyl)-2-thiazolyl)-4-oxo-1,2,3-benzotriazine-3(4h)-propanamide, uniquely identified by the FDA Unique Ingredient Identifier (UNII) R8F88SC626.
Technical mappings include the Chemical Abstracts Service (CAS) Registry Number 1181519-47-0 and the RxNorm Concept ID (RxCUI) N/A. Explore the sections below for detailed nomenclature and a complete directory of NDC-listed products containing this ingredient.
Detailed Substance Profile
C21H19N5O2S NHPOGCOZGXTNFE-UHFFFAOYSA-N Synonyms and Nomenclature
This section provides a complete list of nomenclature and identifier mappings for N-(5-((2-methylphenyl)methyl)-2-thiazolyl)-4-oxo-1,2,3-benzotriazine-3(4h)-propanamide. Identifiers are organized into official regulatory terms, commercial trade names, and technical systematic synonyms used to ensure accurate identification across clinical pharmaceutical databases, regulatory filings, and electronic health records.